H. Asahara, K. Fujisawa, T. Kobata, T. Hasunuma, T. Maeda et al., Direct evidence of high DNA binding activity of transcription factor AP-1 in rheumatoid arthritis synovium, Arthritis & Rheumatism, vol.1180, issue.5, pp.912-928, 1997.
DOI : 10.1002/art.1780400520

R. Marok, P. Winyard, A. Coumbe, M. Kus, K. Gaffney et al., Activation of the transcription factor nuclear factor-??B in human inflamed synovial tissue, Arthritis & Rheumatism, vol.52, issue.4, pp.583-591, 1996.
DOI : 10.1002/art.1780390407

G. Firestein and A. Manning, Signal transduction and transcription factors in rheumatic disease, Arthritis & Rheumatism, vol.380, issue.83, pp.609-621, 1999.
DOI : 10.1002/1529-0131(199904)42:4<609::AID-ANR3>3.0.CO;2-I

B. Grimbacher, W. Aicher, H. Peter, and H. Eibel, Measurement of transcription factor c-fos and EGR-1 mRNA transcription levels in synovial tissue by quantitative RT-PCR, Rheumatology International, vol.17, issue.3, pp.109-112, 1997.
DOI : 10.1007/s002960050018

P. Miossec, Interleukin-17 in rheumatoid arthritis: If T cells were to contribute to inflammation and destruction through synergy, Arthritis & Rheumatism, vol.46, issue.3, pp.594-601, 2003.
DOI : 10.1002/art.10816

M. Chabaud, J. Durand, N. Buchs, F. Fossiez, G. Page et al., Human interleukin-17: A T cell-derived proinflammatory cytokine produced by the rheumatoid synovium, Arthritis & Rheumatism, vol.177, issue.5, pp.963-970, 1999.
DOI : 10.1002/1529-0131(199905)42:5<963::AID-ANR15>3.0.CO;2-E

A. Kehlen, K. Thiele, D. Riemann, and J. Langner, Expression, modulation and signalling of IL-17 receptor in fibroblast-like synoviocytes of patients with rheumatoid arthritis, Clinical & Experimental Immunology, vol.13, issue.3, pp.539-546, 2002.
DOI : 10.1046/j.1365-2249.2002.01782.x

M. Chabaud, G. Page, and P. Miossec, Enhancing Effect of IL-1, IL-17, and TNF-?? on Macrophage Inflammatory Protein-3?? Production in Rheumatoid Arthritis: Regulation by Soluble Receptors and Th2 Cytokines, The Journal of Immunology, vol.167, issue.10, pp.6015-6020, 2001.
DOI : 10.4049/jimmunol.167.10.6015

Y. Katz, O. Nadiv, and Y. Beer, Interleukin-17 enhances tumor necrosis factor ?-induced synthesis of interleukins 1, 6, and 8 in skin and synovial fibroblasts: A possible role as a ?fine-tuning cytokine? in inflammation processes, Arthritis & Rheumatism, vol.164, issue.9, pp.2176-2184, 2001.
DOI : 10.1002/1529-0131(200109)44:9<2176::AID-ART371>3.0.CO;2-4

M. Chabaud, P. Garnero, J. Dayer, P. Guerne, F. Fossiez et al., CONTRIBUTION OF INTERLEUKIN 17 TO SYNOVIUM MATRIX DESTRUCTION IN RHEUMATOID ARTHRITIS, Cytokine, vol.12, issue.7, pp.1092-1099, 2000.
DOI : 10.1006/cyto.2000.0681

F. Fossiez, O. Djossou, P. Chomarat, L. Flores-romo, S. Ait-yahia et al., T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines, Journal of Experimental Medicine, vol.183, issue.6, pp.2593-2603, 1996.
DOI : 10.1084/jem.183.6.2593
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2192621

M. Chabaud and P. Miossec, The combination of tumor necrosis factor ? blockade with interleukin-1 and interleukin-17 blockade is more effective for controlling synovial inflammation and bone resorption in an ex vivo model, Arthritis & Rheumatism, vol.136, issue.6, pp.1293-1303, 2001.
DOI : 10.1002/1529-0131(200106)44:6<1293::AID-ART221>3.0.CO;2-T

A. Legrand, B. Fermor, C. Fink, D. Pisetsky, J. Weinberg et al., Interleukin-1, tumor necrosis factor ?, and interleukin-17 synergistically up-regulate nitric oxide and prostaglandin E2 production in explants of human osteoarthritic knee menisci, Arthritis & Rheumatism, vol.45, issue.9, pp.2078-2083, 2001.
DOI : 10.1002/1529-0131(200109)44:9<2078::AID-ART358>3.0.CO;2-J

R. Van-bezooijen, L. Van-der-wee-pals, S. Papapoulos, and C. Lowik, Interleukin 17 synergises with tumour necrosis factor alpha to induce cartilage destruction in vitro, Annals of the Rheumatic Diseases, vol.61, issue.10, pp.870-876, 2002.
DOI : 10.1136/ard.61.10.870

F. Arnett, S. Edworthy, D. Bloch, D. Mcshane, J. Fries et al., The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis, Arthritis & Rheumatism, vol.143, issue.3, pp.315-324, 1988.
DOI : 10.1002/art.1780310302

M. Ziolkowska, M. Kurowska, A. Radzikowska, G. Luszczykiewicz, P. Wiland et al., High levels of osteoprotegerin and soluble receptor activator of nuclear factor ?B ligand in serum of rheumatoid arthritis patients and their normalization after anti-tumor necrosis factor ? treatment, Arthritis & Rheumatism, vol.43, issue.7, pp.1744-1753, 2002.
DOI : 10.1002/art.10388

M. Chabaud, E. Lubberts, L. Joosten, . Van-den, W. Berg et al., IL-17 derived from juxta-articular bone and synovium contributes to joint degradation in rheumatoid arthritis, Arthritis Research, vol.3, issue.3, pp.168-177, 2001.
DOI : 10.1186/ar294

M. Suzuki, T. Tetsuka, S. Yoshida, N. Watanabe, M. Kobayashi et al., The role of p38 mitogen-activated protein kinase in IL-6 and IL-8 production from the TNF-??- or IL-1??-stimulated rheumatoid synovial fibroblasts, FEBS Letters, vol.361, issue.1, pp.23-27, 2000.
DOI : 10.1016/S0014-5793(99)01717-2

B. Grimbacher, W. Aicher, H. Peter, and H. Eibel, TNF- ???? induces the transcription factor Egr-1, pro-inflammatory cytokines and cell proliferation in human skin fibroblasts and synovial lining cells, Rheumatology International, vol.17, issue.5, pp.185-192, 1998.
DOI : 10.1007/s002960050032

X. Cao, G. Guy, V. Sukhatme, and Y. Tan, Regulation of the Egr- 1 gene by tumor necrosis factor and interferons in primary human fibroblasts, J Biol Chem, vol.267, pp.1345-1349, 1992.

C. Granet and P. Miossec, Combination of the pro-inflammatory cytokines IL-1, TNF-a and IL-17 leads to enhanced and additional recruitment of AP-1 members, Egr-1 and NF-kB in osteoblast-like cells [abstract], Arthritis Research & Therapy, vol.5, issue.Suppl 1, p.38, 2003.
DOI : 10.1186/ar668

M. Benderdour, G. Tardif, J. Pelletier, D. Battista, J. Reboul et al., Interleukin 17 (IL-17) induces collage- nase-3 production in human osteoarthritic chondrocytes via AP- 1 dependent activation: differential activation of AP-1 members by IL-17 and IL-1beta, J Rheumatol, vol.29, pp.1262-1672, 2002.

G. Chevrel, G. Page, C. Granet, N. Streichenberger, A. Varennes et al., Interleukin-17 increases the effects of IL-1?? on muscle cells: arguments for the role of T cells in the pathogenesis of myositis, Journal of Neuroimmunology, vol.137, issue.1-2, pp.125-133, 2003.
DOI : 10.1016/S0165-5728(03)00032-8

K. Hata, A. Andoh, M. Shimada, S. Fujino, S. Bamba et al., IL-17 stimulates inflammatory responses via NF-??B and MAP kinase pathways in human colonic myofibroblasts, American Journal of Physiology - Gastrointestinal and Liver Physiology, vol.282, issue.6, pp.1035-1044, 2002.
DOI : 10.1152/ajpgi.00494.2001

S. Wakisaka, N. Suzuki, M. Takeno, Y. Takeba, H. Nagafuchi et al., Involvement of simultaneous multiple transcription factor expression, including cAMP responsive element binding protein and OCT-1, for synovial cell outgrowth in patients with rheumatoid arthritis, Annals of the Rheumatic Diseases, vol.57, issue.8, pp.487-494, 1998.
DOI : 10.1136/ard.57.8.487

J. Lin and J. Vilcek, Tumor necrosis factor and interleukin-1 cause a rapid and transient stimulation of c-fos and c-myc mRNA levels in human fibroblasts, J Biol Chem, vol.262, pp.11908-11911, 1987.

G. Guy, X. Cao, S. Chua, and Y. Tan, Okadaic acid mimics multiple changes in early protein phosphorylation and gene expression induced by tumor necrosis factor or interleukin-1

D. Haynes, T. Crotti, M. Loric, G. Bain, G. Atkins et al., Osteoprotegerin and receptor activator of nuclear factor kappaB ligand (RANKL) regulate osteoclast formation by cells in the human rheumatoid arthritic joint, Rheumatology, vol.40, issue.6, pp.623-630, 2001.
DOI : 10.1093/rheumatology/40.6.623

A. Feuerherm, M. Borset, C. Seidel, A. Sundan, L. Leistad et al., Elevated levels of osteoprotegerin (OPG) and hepatocyte growth factor (HGF) in rheumatoid arthritis, Scand J Rheumatol, vol.30, pp.229-234, 2001.

K. Yano, N. Nakagawa, H. Yasuda, E. Tsuda, and K. Higashio, Synovial cells from a patient with rheumatoid arthritis produce osteoclastogenesis inhibitory factor/osteoprotegerin: reciprocal regulation of the production by inflammatory cytokines and basic fibroblast growth factor, Journal of Bone and Mineral Metabolism, vol.19, issue.6, pp.365-372, 2001.
DOI : 10.1007/s007740170006

M. Sakata, H. Shiba, H. Komatsuzawa, T. Fujita, K. Ohta et al., Expression of Osteoprotegerin (Osteoclastogenesis Inhibitory Factor) in Cultures of Human Dental Mesenchymal Cells and Epithelial Cells, Journal of Bone and Mineral Research, vol.273, issue.Suppl, pp.1486-1492, 1999.
DOI : 10.1359/jbmr.1999.14.9.1486

P. Collin-osdoby, L. Rothe, F. Anderson, M. Nelson, W. Maloney et al., Receptor Activator of NF-??B and Osteoprotegerin Expression by Human Microvascular Endothelial Cells, Regulation by Inflammatory Cytokines, and Role in Human Osteoclastogenesis, Journal of Biological Chemistry, vol.276, issue.23, pp.20659-20672, 2001.
DOI : 10.1074/jbc.M010153200

O. Vidal, K. Sjogren, B. Eriksson, O. Ljunggren, and C. Ohlsson, Osteoprotegerin mRNA Is Increased by Interleukin-1?? in the Human Osteosarcoma Cell Line MG-63 and in Human Osteoblast-Like Cells, Biochemical and Biophysical Research Communications, vol.248, issue.3, pp.696-700, 1998.
DOI : 10.1006/bbrc.1998.9035

H. Brandstrom, K. Jonsson, O. Vidal, S. Ljunghall, C. Ohlsson et al., Tumor Necrosis Factor-?? and -?? Upregulate the Levels of Osteoprotegerin mRNA in Human Osteosarcoma MG-63 Cells, Biochemical and Biophysical Research Communications, vol.248, issue.3, pp.454-457, 1998.
DOI : 10.1006/bbrc.1998.8993

E. Lubberts, L. Van-den-bersselaar, B. Oppers-walgreen, P. Schwarzenberger, C. Coenen-de-roo et al., IL-17 Promotes Bone Erosion in Murine Collagen-Induced Arthritis Through Loss of the Receptor Activator of NF-??B Ligand/Osteoprotegerin Balance, The Journal of Immunology, vol.170, issue.5, pp.2655-2662, 2003.
DOI : 10.4049/jimmunol.170.5.2655

P. Professor and . Miossec, Departments of Immunology and Rheumatology, Hospital E Herriot, 5 place d'Arsonval, 69437 Lyon cedex 03, France 29; e-mail: miossec@univ-lyon1, Clinical Immunology Unit Arthritis Research & Therapy, vol.6